A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species
- PMID: 15276412
- DOI: 10.1016/j.taap.2003.10.027
A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species
Abstract
This laboratory has studied the enzymology involved in the biotransformation of inorganic arsenic to dimethylarsinous acid (DMA(III)) and in human studies established that monomethylarsonous acid (MMA(III)) and DMA(III) appear in urine of people chronically exposed to arsenic. It appears that only two proteins are required for inorganic arsenic biotransformation in the human, namely, monomethylarsonic acid (MMA(V)) reductase and arsenic methyltransferase. MMA(V) reductase and the unique glutathione transferase omega (hGST-O) are identical proteins. Arsenicals with a +3 oxidation state are more toxic than the +5 species. While methylation of arsenite, MMA(III), and DMA(III) produces less toxic +5 oxidation arsenic species containing an additional methyl group such as MMA(V), dimethylarsinic acid (DMA(V)), and TMAO, a new mechanism involving hydrogen peroxide for detoxifying arsenite, MMA(III), and DMA(III) is proposed based on in vitro experiments.
Similar articles
-
Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.Toxicol Appl Pharmacol. 2004 Dec 1;201(2):156-65. doi: 10.1016/j.taap.2004.05.017. Toxicol Appl Pharmacol. 2004. PMID: 15541755
-
Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.Biometals. 2005 Oct;18(5):493-506. doi: 10.1007/s10534-005-0858-7. Biometals. 2005. PMID: 16333750
-
Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.Chem Res Toxicol. 2004 Jan;17(1):95-103. doi: 10.1021/tx0341714. Chem Res Toxicol. 2004. PMID: 14727923 Clinical Trial.
-
The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.Toxicol Appl Pharmacol. 2004 Aug 1;198(3):458-67. doi: 10.1016/j.taap.2003.10.023. Toxicol Appl Pharmacol. 2004. PMID: 15276427 Review.
-
Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.Crit Rev Toxicol. 2006 Feb;36(2):99-133. doi: 10.1080/10408440500534230. Crit Rev Toxicol. 2006. PMID: 16736939 Review.
Cited by
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
-
Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells.Int J Mol Sci. 2023 Jan 23;24(3):2282. doi: 10.3390/ijms24032282. Int J Mol Sci. 2023. PMID: 36768603 Free PMC article.
-
Arsenic-Related Health Risk Assessment of Realgar-Containing NiuHuangJieDu Tablets in Healthy Volunteers Po Administration.Front Pharmacol. 2022 Jan 7;12:761801. doi: 10.3389/fphar.2021.761801. eCollection 2021. Front Pharmacol. 2022. PMID: 35069195 Free PMC article.
-
Enhanced Bioaccumulation and Toxicity of Arsenic in Marine Mussel Perna viridis in the Presence of CuO/Fe3O4 Nanoparticles.Nanomaterials (Basel). 2021 Oct 19;11(10):2769. doi: 10.3390/nano11102769. Nanomaterials (Basel). 2021. PMID: 34685209 Free PMC article.
-
Melatonin: a pleiotropic hormone as a novel potent therapeutic candidate in arsenic toxicity.Mol Biol Rep. 2021 Sep;48(9):6603-6618. doi: 10.1007/s11033-021-06669-3. Epub 2021 Aug 28. Mol Biol Rep. 2021. PMID: 34453671 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases